No definition available.
Maternal care for known or suspected disproportion
EFO MESH Endpoint Browser PheWeb
O15_MATERN_CARE_DISPROP
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1821 |
4. Check minimum number of eventsNone |
1821 |
5. Include endpointsNone |
1821 |
6. Filter based on genotype QC (FinnGen only) |
1821 |
Control definitions (FinnGen only)
- Control exclude
- O15_MATERN_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- O30-O48
- Name in latin
- Cura matris propter disproportionem fetopelvinam notam sive suspectam
Similar endpoints
↥List of similar endpoints to
Maternal care for known or suspected disproportion
based on the number of shared cases.
Similar with more cases:
- Maternal care related to the fetus and amniotic cavity and possible delivery problems
- Delivery, wide proxy
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13757 | 13757 | - |
| Only index persons | 13623 | 13623 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.39 | 0.39 | - |
| Only index persons | 0.50 | 0.50 | - |
| Median age at first event (years) | |||
| Whole population | - | 30.64 | - |
| Only index persons | - | 30.64 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1821 | 1821 | - |
| Unadjusted period prevalence (%) | 0.62 | 0.62 | - |
| Median age at first event (years) | 30.88 | 30.88 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1637
- Matched controls
- 16370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O82.0
ICD-10 Finland
Delivery by elective caesarean section
115.8
323.0
805
136
O33.5
ICD-10 Finland
Maternal care for disproportion due to unusually large fetus
+∞
323.0
350
*
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
16384.0
323.0
872
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
86.9
323.0
1271
628
O33.9
ICD-10 Finland
Maternal care for disproportion, unspecified
+∞
323.0
401
*
O33.3
ICD-10 Finland
Maternal care for disproportion due to outlet contraction of pelvis
+∞
323.0
313
*
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
19.5
304.1
485
345
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
+∞
270.5
252
*
O33.1
ICD-10 Finland
Maternal care for disproportion due to generally contracted pelvis
+∞
261.7
244
*
O32.1
ICD-10 Finland
Maternal care for breech presentation
1136.5
209.1
200
*
O33.4
ICD-10 Finland
Maternal care for disproportion of mixed maternal and fetal origin
+∞
194.8
183
*
O33.2
ICD-10 Finland
Maternal care for disproportion due to inlet contraction of pelvis
+∞
168.7
159
*
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
18.1
165.7
266
173
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
4.0
147.0
907
3899
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
535.4
102.8
101
*
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
4.7
95.8
370
955
O48
ICD-10 Finland
Prolonged pregnancy
+∞
95.8
91
*
O33.0
ICD-10 Finland
Maternal care for disproportion due to deformity of maternal pelvic bones
+∞
92.6
88
*
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
14.1
85.0
149
115
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
4.6
84.8
334
870
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
3.5
82.6
466
1665
8811
FHL
Cesarean section
5.4
81.5
269
577
ZXD05
NOMESCO Finland
Urgent procedure
2.9
80.8
663
3083
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
3.1
76.5
529
2174
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
4.9
74.9
267
621
O65.4
ICD-10 Finland
Obstructed labour due to fetopelvic disproportion, unspecified
30.6
64.8
87
30
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
+∞
60.8
58
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
2.8
60.0
489
2174
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.3
59.8
108
3606
O40
ICD-10 Finland
Polyhydramnios
599.0
59.1
58
*
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
566.7
55.9
55
*
O65.3
ICD-10 Finland
Obstructed labour due to pelvic outlet and mid-cavity contraction
87.5
53.2
59
7
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
+∞
52.4
50
*
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
17.2
49.5
79
48
O41.0
ICD-10 Finland
Oligohydramnios
+∞
49.2
47
*
O65.1
ICD-10 Finland
Obstructed labour due to generally contracted pelvis
44.4
48.8
60
14
O30.0
ICD-10 Finland
Twin pregnancy
+∞
48.2
46
*
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
5.6
46.7
144
279
MAA00
NOMESCO Finland
Amniocentesis
9.1
42.8
92
106
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
428.3
42.4
42
*
O33.8
ICD-10 Finland
Maternal care for disproportion of other origin
+∞
41.8
40
*
6533B
ICD-9 Finland
Disproportion, Outlet contraction of pelvis[PELVIS ANGUSTA, ANOM APERT INFER,SYNNYTYKSEN AIKANA]
25.0
41.2
58
24
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
+∞
39.7
38
*
WX320
NOMESCO Finland
Spinalanesthesy
2.6
39.3
326
1417
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
7.9
38.6
90
119
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
38.4
668
4125
Z30.2
ICD-10 Finland
Sterilization
2.4
36.9
354
1662
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
6.6
36.5
97
155
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
10.6
36.5
72
71
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
2.5
36.0
334
1537
O99.80
ICD-10 Finland
The fear of childbirth
3.9
35.9
155
423
XMA22
NOMESCO Finland
General examination of pregnant woman
3.1
35.8
216
765
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
+∞
34.5
33
*
NE1AG
NOMESCO Finland
MRI pelvimetry with high intensity magnet
94.6
33.8
37
*
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
7.8
32.5
76
101
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.5
31.7
270
1177
O42.0
ICD-10 Finland
Premature rupture of membranes, onset of labour within 24 hours
+∞
31.3
30
*
Z36.8
ICD-10 Finland
Other antenatal screening
5.3
31.3
99
197
O65.2
ICD-10 Finland
Obstructed labour due to pelvic inlet contraction
61.3
31.2
36
6
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.9
30.7
199
737
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
2.2
30.6
362
1860
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
+∞
30.3
29
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.4
30.2
296
1389
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
5.1
29.4
95
194
MCA96
NOMESCO Finland
Other caesarean section
65.2
28.0
32
5
O42.1
ICD-10 Finland
Premature rupture of membranes, onset of labour after 24 hours
+∞
27.2
26
*
O32.2
ICD-10 Finland
Maternal care for transverse and oblique lie
137.2
25.7
27
*
SPAT1196
SPAT
Monitoring of normal pregnancy
2.8
25.1
177
686
6531B
ICD-9 Finland
Disproportion, Generally contracted pelvis[PELVIS ANGUSTA,SYNNYTYKSEN AIKANA]
11.5
24.2
45
40
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.5
22.9
201
882
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
2.9
22.6
147
541
LGA00
NOMESCO Finland
Sterilisation by ligature of Fallopian tubes
11.0
21.7
41
38
MAB20
NOMESCO Finland
Failed external version
116.6
21.6
23
*
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
4.7
21.3
73
160
MCA00
NOMESCO Finland
Upper uterine segment caesarean section
50.7
21.1
25
5
O61.0
ICD-10 Finland
Failed medical induction of labour
9.6
21.1
43
46
O20.0
ICD-10 Finland
Threatened abortion
3.7
20.6
91
253
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
+∞
19.8
19
*
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.8
18.9
128
485
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
18.0
106
367
W84
ICPC
Pregnancy high risk
4.1
17.9
70
175
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
181.9
17.5
18
*
J01DA01
ATC
[U] cefalexin; systemic
1.6
17.1
1073
8929
MAC96
NOMESCO Finland
Other induction or advancement of labour
3.7
17.0
76
215
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
2.9
16.9
108
395
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
+∞
16.7
16
*
ZXE00
NOMESCO Finland
One hour or less
1.6
16.5
616
4501
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
2.7
16.4
117
458
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
8.5
16.2
35
42
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.9
16.0
249
1401
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
15.8
460
6267
6534B
ICD-9 Finland
Disproportion, Foetopelvic disproportion[DISPROPORTIO FOETOPELVICA,SYNNYTYKSEN AIKANA]
6.9
15.8
39
58
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
8.8
15.7
33
38
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
+∞
15.6
15
*
O32.0
ICD-10 Finland
Maternal care for unstable lie
+∞
15.6
15
*
SPAT1197
SPAT
Extensive health check-up of expecting family
2.0
15.5
217
1171
O86.0
ICD-10 Finland
Infection of obstetric surgical wound
7.3
15.3
36
50
SPAT1379
SPAT
Health check-up of pregnant person
2.2
15.1
168
825
O36.4
ICD-10 Finland
Maternal care for intrauterine death
+∞
14.6
14
*
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
36.4
14.4
18
5
W92
ICPC
Compl labour/ delivery livebirth
6.1
14.1
38
64
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
2.4
14.0
120
519
O41.8
ICD-10 Finland
Other specified disorders of amniotic fluid and membranes
+∞
13.6
13
*
Z37.0
ICD-10 Finland
Single live birth
1.8
13.5
269
1635
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
3.2
13.5
71
229
SPAT1357
SPAT
Monitoring of problem during pregnancy
3.4
13.1
64
196
O66.5
ICD-10 Finland
Failed application of vacuum extractor and forceps, unspecified
10.6
12.8
24
23
O83.8
ICD-10 Finland
Other specified assisted single delivery
12.4
12.6
22
18
MAB10
NOMESCO Finland
External version
32.3
12.6
16
5
NE1MA
NOMESCO Finland
Birth channel measurement with X-ray
+∞
12.5
12
*
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.3
12.5
25
834
O02.1
ICD-10 Finland
Missed abortion
2.0
12.3
158
819
O47.9
ICD-10 Finland
False labour, unspecified
10.6
12.3
23
22
H04AA01
ATC
glucagon; nasal, parenteral
3.6
12.2
54
153
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
6.3
12.0
31
50
6531A
ICD-9 Finland
Disproportion, Generally contracted pelvis[PELVIS ANGUSTA,RASKAUDEN AIKANA]
11.8
11.8
21
18
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
5.9
11.8
32
55
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.0
11.7
46
118
G03DA04
ATC
progesterone; systemic, rectal, vaginal
2.4
11.5
99
431
6441A
ICD-9 Finland
Early or threatened labour, Other threatened labour
+∞
11.5
11
*
SPAT1380
SPAT
Postpartum check-up
2.1
11.3
137
697
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
7.7
11.2
25
33
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
11.0
481
3564
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.7
11.0
238
1480
WX290
NOMESCO Finland
Other blockade of nerve
1.4
10.9
804
6611
O65.0
ICD-10 Finland
Obstructed labour due to deformed pelvis
43.6
10.9
13
*
O28.1
ICD-10 Finland
Abnormal biochemical finding on antenatal screening of mother
5.3
10.9
32
61
O65.5
ICD-10 Finland
Obstructed labour due to abnormality of maternal pelvic organs
21.6
10.7
15
7
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.0
10.7
59
199
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.6
10.7
75
293
J01CA08
ATC
pivmecillinam; oral
1.4
10.6
797
6562
MAW96
NOMESCO Finland
Other operation in pregnancy or at delivery
7.0
10.6
25
36
MAE20
NOMESCO Finland
Failed vacuum delivery
14.3
10.5
17
12
O44.1
ICD-10 Finland
Placenta praevia with haemorrhage
110.7
10.4
11
*
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
+∞
10.4
10
*
O44.0
ICD-10 Finland
Placenta praevia specified as without haemorrhage
+∞
10.4
10
*
O34.0
ICD-10 Finland
Maternal care for congenital malformation of uterus
+∞
10.4
10
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.8
10.0
63
230
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.1
9.9
113
562
J01DB01
ATC
cefalexin; oral
1.5
9.9
1288
11679
A10AA01
ATC
NA
2.9
9.7
56
195
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.1
9.6
51
168
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
9.6
83
362
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
9.4
214
1347
SPAT1200
SPAT
Guidance for breast-feeding and breast care
3.0
9.4
51
171
O46.8
ICD-10 Finland
Other antepartum haemorrhage
+∞
9.4
9
*
O36.0
ICD-10 Finland
Maternal care for rhesus isoimmunization
+∞
9.4
9
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
9.2
974
8428
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
5.8
9.2
25
44
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
9.1
144
810
A10AA02
ATC
NA
2.8
9.0
54
194
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
18.7
8.9
13
7
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
2.2
8.9
92
439
6534A
ICD-9 Finland
Disproportion, Foetopelvic disproportion[DISPROPORTIO FOETOPELVICA,RASKAUDEN AIKANA]
12.6
8.9
15
12
ZXH09
SPAT
NA
2.8
8.9
54
196
SPAT1189
SPAT
Other ultrasound examination during pregnancy
2.8
8.8
55
200
O82.9
ICD-10 Finland
Delivery by caesarean section, unspecified
50.3
8.7
10
*
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.7
8.6
170
1025
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.7
8.6
28
61
A10AE05
ATC
insulin detemir; parenteral
2.5
8.6
66
274
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.8
8.5
154
906
O62.0
ICD-10 Finland
Primary inadequate contractions
6.7
8.4
20
30
O34.8
ICD-10 Finland
Maternal care for other abnormalities of pelvic organs
+∞
8.3
8
*
O33.7
ICD-10 Finland
Maternal care for disproportion due to other fetal deformities
+∞
8.3
8
*
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
+∞
8.3
8
*
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
4.3
8.2
29
69
O66.2
ICD-10 Finland
Obstructed labour due to unusually large fetus
11.8
8.1
14
12
Z36.9
ICD-10 Finland
Antenatal screening, unspecified
2.6
8.0
55
214
G02CB01
ATC
bromocriptine; systemic
2.6
7.9
56
223
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.5
7.9
61
253
R21
ICPC
Throat symptom/complaint
1.5
7.8
348
2567
6620B
ICD-9 Finland
Long labour, Prolonged first stage
5.9
7.7
20
34
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.7
420
3220
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
2.7
7.6
49
184
G02BA03
ATC
plastic IUD with progestogen
1.4
7.6
425
3270
SPAT1263
SPAT
Sampling
1.4
7.5
549
4424
A10AE04
ATC
insulin glargine; parenteral
2.1
7.4
82
406
T89
ICPC
Diabetes insulin dependent
2.5
7.4
55
225
Z3232
NOMESCO Finland
Midwife
1.6
7.3
207
1379
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
0.1
7.3
*
238
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.2
948
8328
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
3.4
7.2
33
99
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
4.3
7.2
25
59
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
2.2
7.2
69
321
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
7.1
657
5477
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
4.0
7.1
26
65
65400
ICD-8 Finland
Occipital presentation
5.9
6.9
18
31
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.8
6.9
41
148
ACC51
NOMESCO Finland
Release of median nerve
1.8
6.8
113
647
ZXD00
NOMESCO Finland
Emergency procedure
2.5
6.8
51
207
6533A
ICD-9 Finland
Disproportion, Outlet contraction of pelvis[PELVIS ANGUSTA, ANOM APERT INFER,RASKAUDEN AIKANA]
9.3
6.8
13
14
W78
ICPC
Pregnancy
1.5
6.8
211
1438
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.7
924
8134
O60
ICD-10 Finland
Preterm labour and delivery
3.1
6.7
34
111
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
6.7
185
1225
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
6.5
6.6
16
25
MAC00
NOMESCO Finland
Rupture of amniotic membrane
6.5
6.6
16
25
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
3.3
6.6
30
91
6532B
ICD-9 Finland
Disproportion, Inlet contraction of pelvis[PELVIS ANGUSTA, ANOM APERT SUPER,SYNNYTYKSEN AIKANA]
8.7
6.6
13
15
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.5
6.5
258
1852
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
6.9
6.5
15
22
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.0
6.5
73
365
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
6.4
39
816
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.4
185
1242
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
6.4
161
1044
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
2.0
6.4
76
388
O68.1
ICD-10 Finland
Labour and delivery complicated by meconium in amniotic fluid
4.4
6.4
21
48
SPAT1262
SPAT
Handing over of treatment supplies
1.7
6.3
138
861
MWE00
NOMESCO Finland
Reoperation for deep haemorrhage in obstetric surgery
18.1
6.3
9
5
O34.9
ICD-10 Finland
Maternal care for abnormality of pelvic organ, unspecified
+∞
6.3
6
*
6582B
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Delayed delivery after spontaneous or unspecified rupture of membranes
+∞
6.3
6
*
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
+∞
6.3
6
*
O34.4
ICD-10 Finland
Maternal care for other abnormalities of cervix
+∞
6.3
6
*
6450B
ICD-9 Finland
Prolonged pregnancy[GRAVIDITAS PROLANGATA CUM PARTU]
+∞
6.3
6
*
6581A
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Premature rupture of membranes
+∞
6.3
6
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.2
1066
9623
WX600
NOMESCO Finland
Single shot through catheter
2.6
6.2
41
158
O03.6
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, complicated by delayed or excessive haemorrhage
4.1
6.2
22
54
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
2.9
6.2
36
128
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
3.7
6.2
25
69
TLC02
NOMESCO Finland
Simple extraction of IUD
1.7
6.2
126
773
N02BE01
ATC
paracetamol; systemic, rectal
1.4
6.1
1281
11900
MAA96
NOMESCO Finland
Other intrauterine operation on pregnant uterus or fetus
8.6
6.1
12
14
Z39.1
ICD-10 Finland
Care and examination of lactating mother
2.6
6.0
40
155
Z31.5
ICD-10 Finland
Genetic counselling
1.8
6.0
93
521
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
47
105
4.57
19.67
1.4
1.3
mmol/l
7.5
8.1
0.63
28
64
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
93
334
2.88
19.18
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
406
2831
1.56
12.95
3.5
3.0
kg/l
1.0
1.0
0.67
70
369
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
57
228
2.55
9.66
1.3
1.3
mmol/l
6.6
7.2
0.88
41
179
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
57
243
2.39
8.48
1.4
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1009
8770
1.34
8.38
3.5
3.4
e6/l
72.8
790.1
2.78
12
90
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
65
299
2.22
8.13
2.1
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
248
1722
1.51
7.78
1.8
1.7
—
—
—
0
0
(4034850)
85
442
1.97
7.72
7.3
6.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
104
583
1.83
7.53
1.5
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
538
4370
1.33
6.74
1.9
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1481
13849
1.37
6.33
3.8
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
412
3265
1.34
6.02
2.0
2.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1568
14872
1.39
5.53
8.2
9.1
mmol/l
3.9
3.9
0.43
1529
14484
(3019550) Sodium [Moles/volume] in Serum or Plasma
1562
14811
1.38
5.47
8.1
9.0
mmol/l
139.6
139.6
0.33
1526
14460
(3034274) Bile acid [Moles/volume] in Serum --fasting
41
187
2.22
5.34
2.1
1.8
umol/l
5.1
5.3
0.05
33
135
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1561
14845
1.36
4.98
5.0
4.9
mu/l
1.7
2.0
1.17
1505
14289
(40761511) CBC panel - Blood by Automated count
1708
16516
1.55
4.88
8.9
8.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
640
5500
1.25
4.84
3.1
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
243
1853
1.36
4.52
2.4
2.8
ng/l
32.4
476.5
2.89
111
902
(3003694) ABO and Rh group [Type] in Blood
339
4164
0.77
4.41
1.7
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
62
1041
0.58
4.33
3.4
4.3
%
0.4
0.7
—
8
193
(3010813) Leukocytes [#/volume] in Blood
1793
17612
2.17
4.22
14.2
14.8
e9/l
6.6
6.6
0.10
1772
17309
(3025159) Blasts/100 leukocytes in Blood
63
1042
0.59
4.16
3.7
4.5
%
0.0
0.4
—
10
205
(3026361) Erythrocytes [#/volume] in Blood
1792
17606
2.12
4.09
14.1
14.8
e12/l
4.5
4.5
0.52
1771
17321
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
48
261
1.86
3.96
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1790
17587
2.05
3.96
14.2
14.8
e9/l
273.7
275.9
0.87
1773
17311
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
125
871
1.47
3.91
1.4
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
25
4.02
3.70
1.1
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
471
4012
1.23
3.69
2.0
2.5
u/l
53.8
55.3
0.38
451
3777
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
200
0.25
3.68
12.0
12.1
nmol/l
833.8
913.9
—
5
195
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1400
13260
1.24
3.67
4.3
4.3
pmol/l
14.1
14.2
0.45
1358
12656
(3021440) Promyelocytes/100 leukocytes in Blood
69
1080
0.62
3.66
3.7
4.6
%
0.3
0.3
0.02
14
240
(3044640) Blood type and Crossmatch panel - Blood
476
4071
1.23
3.57
1.8
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
287
2317
1.28
3.56
2.1
2.3
e6/l
7.3
8.8
1.00
250
2024
(36660697) Celiac disease serology panel - Serum
185
1405
1.35
3.55
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1026
9446
1.20
3.53
3.5
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
1003
0.62
3.43
2.0
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
75
1128
0.65
3.34
3.6
4.5
%
1.1
0.9
0.25
15
263
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1689
16429
1.39
3.27
8.2
8.3
u/l
24.9
24.1
0.99
1668
16109
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
452
3885
1.22
3.20
1.9
2.3
ng/l
16.2
25.8
0.72
158
1440
(3011397) Hemoglobin [Presence] in Urine by Test strip
350
2930
1.24
3.18
3.4
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
397
3372
1.23
3.15
2.4
2.7
e6/l
44.3
103.5
1.09
306
2525
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
22
453
0.48
3.08
2.4
1.3
ug/l
5.5
2.7
0.43
16
392
(3013826) Glucose [Moles/volume] in Serum or Plasma
755
6824
1.18
3.04
3.2
3.7
mmol/l
6.5
6.3
1.51
690
6384
(36304419) Bacteria [Presence] in Urine
364
3078
1.23
3.01
2.2
2.5
—
—
—
0
0
(4035726)
76
1112
0.67
2.98
1.5
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
51
311
1.66
2.93
3.9
4.8
mmol/l
1.3
1.2
0.32
46
277
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1367
13012
1.20
2.92
4.5
4.0
mmol/mol
38.5
37.4
4.11
1324
12496
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
21
96
2.20
2.83
3.4
1.6
%
98.3
102.1
0.21
21
89
(3001122) Ferritin [Mass/volume] in Serum or Plasma
930
8584
1.17
2.83
3.1
3.0
ug/l
60.0
68.5
3.31
896
8268
(3030467) Casts [#/volume] in Urine by Automated count
358
3051
1.22
2.73
2.3
2.6
e6/l
0.2
0.3
2.24
269
2217
(3021601) Nitrite [Presence] in Urine by Test strip
758
6899
1.17
2.72
4.3
4.1
estimate
0.0
0.0
0.40
98
1279
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
373
3195
1.21
2.70
1.8
2.0
u/l
172.3
146.0
0.24
360
3064
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1599
15495
1.26
2.70
3.9
3.6
mmol/l
3.0
3.0
1.04
1544
14885
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
387
3327
1.21
2.70
1.4
1.3
u/ml
8.2
8.9
0.08
164
1496
(3033799) Differential panel - Peritoneal fluid
8
19
4.22
2.68
2.3
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
126
946
1.36
2.66
1.3
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
59
885
0.66
2.64
3.2
3.3
mmol/l
1.2
1.2
0.20
54
790
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1589
15394
1.25
2.64
3.7
3.4
mmol/l
4.9
5.0
0.85
1551
14887
(3009261) Glucose [Presence] in Urine by Test strip
763
6969
1.16
2.58
3.2
3.0
estimate
0.0
0.0
1.30
99
1242
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1583
15340
1.24
2.55
3.6
3.4
mmol/l
1.5
1.6
8.04
1540
14805
(3035350) Ketones [Presence] in Urine by Test strip
753
6881
1.16
2.51
3.1
2.9
estimate
0.0
0.0
0.00
95
1228
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
38
224
1.71
2.51
1.2
1.1
iu/ml
15.0
1427.6
—
7
54
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
406
3538
1.19
2.43
1.6
1.7
mg/l
0.7
0.7
0.14
298
2643
(3020682) Albumin/Creatinine [Ratio] in Urine
302
2561
1.21
2.42
3.7
3.8
mg/mmol
2.1
7.7
7.48
191
1579
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1119
10548
1.16
2.41
5.9
6.8
u/l
70.4
72.3
1.00
1057
10052
(1616796) Gas panel - Central venous blood
7
191
0.36
2.41
3.0
3.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
398
3471
1.19
2.36
1.4
1.3
iu/ml
20.7
23.0
0.16
138
1094
(40761535) Cells panel - Urine sediment
114
861
1.35
2.35
3.5
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
630
5706
1.16
2.33
4.7
5.5
mmol/l
1.2
1.2
0.10
560
4858
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
185
0.38
2.28
1.0
1.3
nmol/l
46.2
29.9
—
7
160
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1487
14361
1.19
2.25
3.4
3.4
mmol/l
5.7
5.6
1.25
1430
13738
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
128
1.89
2.21
1.5
1.3
mmol/l
10.6
12.6
—
5
27
(3007853) Bacteria identified in Skin by Aerobe culture
187
1525
1.25
2.18
1.5
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
693
6348
1.15
2.16
3.6
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
253
2136
1.21
2.13
2.1
2.4
mosm/kgh2o
542.9
527.3
0.47
215
1820
(3044889) 12 lead EKG panel
994
9339
1.14
2.11
2.4
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
218
1815
1.23
2.11
1.8
2.2
e6/l
2.8
1.2
0.37
125
960
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
391
3442
1.17
2.06
1.7
1.6
mmol/l
1.4
1.4
0.00
354
3081
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
342
2981
1.18
2.04
1.7
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
23
125
1.85
2.03
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1582
15401
1.21
2.00
9.2
9.8
mg/l
18.6
17.7
0.45
1235
11565
(3014051) Protein [Presence] in Urine by Test strip
38
240
1.60
1.99
1.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
118
920
1.30
1.99
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
288
2479
1.19
1.98
3.3
3.2
mg/l
264.0
586.1
0.61
181
1462
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
57
2.29
1.97
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
632
1.36
1.97
1.4
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
21
3.34
1.96
2.4
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
27
2.97
1.93
3.9
1.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
120
1.84
1.93
2.3
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
724
6692
1.14
1.92
4.9
5.5
umol/l
9.7
9.3
0.70
677
6342
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1661
16260
1.24
1.91
9.4
10.1
umol/l
64.6
66.1
1.96
1661
16254
(3022621) pH of Urine by Test strip
105
813
1.31
1.87
2.6
2.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
82
613
1.35
1.86
1.1
1.1
u/ml
3.1
4.3
0.19
17
115
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
332
2915
1.17
1.81
1.7
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
168
1.68
1.81
2.4
2.5
ug/min
5.1
126.3
2.75
15
115
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
461
4160
1.14
1.74
1.3
1.3
u/ml
1.2
1.4
0.22
132
1218
(3000330) Specific gravity of Urine by Test strip
63
462
1.38
1.64
1.8
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
475
4312
1.14
1.63
2.7
3.1
e6/l
62.3
55.9
0.13
338
2828
(4062490)
9
187
0.48
1.62
1.0
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
558
5120
1.13
1.62
4.2
4.3
g/l
37.4
37.1
0.78
535
4827
(3002385) Erythrocyte distribution width [Ratio]
1396
13515
1.14
1.61
11.0
12.0
%
13.5
13.6
0.18
1373
13282
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
48
337
1.44
1.60
3.9
4.5
%
1.7
1.8
0.28
43
320
(3006653) Thiamine [Moles/volume] in Blood
16
84
1.91
1.59
1.6
1.8
nmol/l
132.1
129.7
0.09
16
84
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
20
3.01
1.58
1.5
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
26
2.70
1.58
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
93
732
1.29
1.52
1.2
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
186
1580
1.20
1.52
3.2
2.4
umol/l
4.6
5.7
1.69
162
1338
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
14
72
1.95
1.49
1.0
1.0
%
119.1
120.5
0.06
14
66
(3019897) Erythrocyte distribution width [Ratio] by Automated count
57
419
1.37
1.48
2.3
2.3
%
13.1
13.2
0.16
57
413
(3008898) HLA-B27 [Presence]
114
925
1.25
1.46
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
460
0.67
1.43
1.8
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
56
748
0.74
1.42
1.3
1.4
u/l
31.5
28.6
0.30
48
618
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
142
1.63
1.38
1.0
1.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
150
1264
1.20
1.35
4.4
5.6
mmol/l
1.1
1.0
1.32
143
1208
(3023323) Follitropin [Units/volume] in Serum or Plasma
295
2630
1.15
1.33
1.3
1.3
iu/l
31.8
30.6
0.23
273
2302
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1517
14820
1.14
1.33
3.3
3.1
mmol/l
1.2
1.2
0.63
1475
14287
(3021589) Normoblasts [#/volume] in Blood
604
6470
0.90
1.33
6.2
7.9
e9/l
0.0
0.0
0.57
475
5307
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
7
147
0.47
1.32
2.9
3.6
u/ml
32.2
292.9
—
7
139
(1002224) Polysomnography panel
118
974
1.23
1.31
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
355
0.64
1.30
1.2
1.3
ug/g
360.6
316.0
0.38
12
178
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
540
5006
1.11
1.28
4.0
4.8
mmol/l
1.2
1.2
0.41
503
4647
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
48
2.09
1.27
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
411
0.68
1.26
1.6
1.8
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
28
187
1.51
1.24
1.0
1.0
u/ml
1.4
0.4
—
10
45
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
81
1008
0.79
1.24
1.6
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
13
70
1.86
1.24
1.0
1.0
%
115.2
97.8
—
6
22
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
70
1.86
1.24
1.0
1.0
%
108.8
91.7
—
6
22
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
72
566
1.28
1.23
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
45
2.00
1.23
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1162
11205
1.10
1.22
3.7
3.7
mm/h
8.9
9.4
1.20
1109
10649
(3042733) HLA Ab [Presence] in Serum
8
38
2.11
1.18
5.1
4.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
149
1.55
1.17
1.3
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
224
1980
1.15
1.16
1.6
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
567
5297
1.10
1.15
3.4
3.0
u/l
28.5
28.1
0.09
547
5078
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
280
2515
1.13
1.15
1.4
1.5
pmol/l
32422302.8
41326734.0
0.10
256
2277
(3009508) Creatinine [Moles/volume] in Urine
333
3024
1.12
1.14
3.1
3.1
mmol/l
8.4
7.6
2.16
299
2653
(3045414) Leukocytes [Presence] in Urine
72
573
1.27
1.13
1.7
1.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
58
1.90
1.12
3.1
3.8
umol/l
242.6
208.5
—
5
36
(3023368) Bacteria identified in Blood by Culture
266
2386
1.13
1.12
2.7
3.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
243
1.41
1.10
4.4
3.1
mg/l
18.6
20.3
0.17
23
154
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
316
0.66
1.09
3.1
3.6
e9/l
3.8
4.0
0.17
21
316
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
21
316
0.66
1.09
3.6
3.0
mg/l
1.5
1.3
0.34
21
305
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
66
1.82
1.09
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
194
1707
1.15
1.08
1.9
2.4
e6/l
4.5
4.7
0.08
105
863
(3019060) Gas panel - Arterial blood
60
470
1.29
1.08
3.8
4.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
191
1679
1.15
1.08
1.7
1.7
nmol/l
1189.3
1200.6
0.07
168
1360
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
223
1982
1.14
1.08
2.1
2.4
mmol/l
2.4
2.4
3.06
192
1757
(40761536) Microorganisms panel - Urine sediment
91
1097
0.82
1.07
3.0
3.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
325
0.67
1.05
3.0
3.7
%
55.8
57.1
0.34
22
325
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
122
0.49
1.05
2.3
3.1
nmol/l
2.5
3.0
—
6
114
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
506
4721
1.10
1.05
1.8
1.8
pmol/l
101.6
101.3
0.05
269
2584
(3029937) Albumin [Presence] in Urine by Test strip
376
3456
1.11
1.05
3.7
3.2
estimate
0.0
0.0
0.42
97
1266
(40760892) CBC W Ordered Manual Differential panel - Blood
375
4070
0.90
1.04
3.2
4.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
80
653
1.24
1.04
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
147
0.54
1.03
1.3
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
106
1.61
1.03
4.2
2.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
25
171
1.47
1.02
1.0
1.0
u/ml
0.6
0.2
—
6
28
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
298
0.67
1.01
1.6
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
460
4281
1.10
1.00
2.9
3.4
mmol/l
2.3
2.3
3.07
418
3937
(40760888) Immunoglobulin light chains.free panel - Serum
7
132
0.53
0.99
1.4
3.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
234
0.64
0.95
1.1
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
37
1.90
0.94
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
127
1096
1.17
0.94
1.7
2.2
ml/min/173m2
81.1
80.7
0.03
37
431
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
46
356
1.30
0.93
2.0
1.7
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
28
2.15
0.91
1.2
1.3
%
35.0
36.5
—
6
22
(3025941) Bacteria identified in Stool by Culture
91
1075
0.84
0.89
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
363
3360
1.10
0.89
2.1
2.2
mg/l
2.4
2.7
4.11
322
2940
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
6
29
2.07
0.89
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
136
1186
1.16
0.89
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
42
1.91
0.88
5.4
2.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
131
0.53
0.87
1.0
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
60
486
1.24
0.86
4.8
6.3
mmol/l
23.7
24.4
0.61
55
458
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
90
1060
0.84
0.86
3.4
2.2
g/l
0.2
0.2
1.95
85
1007
(3026493) Urate [Moles/volume] in Serum or Plasma
351
3250
1.10
0.86
1.8
2.0
umol/l
291.8
2109.3
4.70
314
2969
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
40
514
0.77
0.86
2.2
2.8
kpa
5.0
5.1
0.64
35
484
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
167
0.60
0.85
1.8
1.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
91
1067
0.85
0.83
1.5
1.7
mu/l
323.4
337.7
0.07
85
945
(3004616) Nuclear Ab [Presence] in Serum
26
188
1.39
0.83
1.5
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
190
0.63
0.83
2.4
2.9
mmol/l
1.7
2.3
—
5
130
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
283
0.70
0.81
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
47
1.71
0.80
1.1
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
38
486
0.78
0.80
1.3
1.3
u/ml
62.6
28.4
—
6
52
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
282
0.71
0.79
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
58
1.73
0.79
2.2
2.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
66
1.67
0.78
1.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
34
1.77
0.76
2.2
2.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
15
99
1.52
0.75
1.3
1.2
—
39.8
—
0
5
(3041096) Erythrocytes [Presence] in Urine by Automated
443
4171
1.08
0.75
2.5
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
492
0.79
0.75
2.2
2.7
mmol/l
0.8
1.1
0.20
25
347
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
75
1.60
0.75
1.0
1.0
—
—
—
0
0
(4198724)
12
75
1.60
0.75
2.0
4.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
19
133
1.43
0.73
1.2
1.1
nmol/l
451.5
426.7
0.21
19
128
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
133
1.43
0.73
1.1
1.2
ratio
1.0
1.0
—
6
46
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
167
1.38
0.73
1.3
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
133
1178
1.14
0.73
1.3
1.2
au/ml
24.6
32.8
—
9
45
(1617658) Protocol used for examination of sentinel lymph nodes
12
183
0.65
0.72
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
40
1.75
0.71
1.6
1.6
—
—
—
0
0
(4146454)
9
57
1.58
0.71
1.2
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
533
5066
1.07
0.70
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
134
1503
0.88
0.70
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
677
6489
1.07
0.70
2.5
2.3
nmol/l
74.8
74.3
0.19
643
6159
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
58
1.55
0.69
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
110
1.46
0.68
1.1
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
429
1.22
0.67
1.2
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
121
0.58
0.67
1.6
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
57
476
1.20
0.66
1.0
1.1
u/ml
3.5
4.8
0.29
24
236
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
128
1.41
0.65
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
78
1.54
0.65
1.5
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
257
2381
1.09
0.65
1.4
1.5
nmol/l
20.7
20.6
0.05
240
2185
(40758558) Short blood count panel - Blood
399
3765
1.08
0.64
5.7
7.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
177
0.68
0.63
1.7
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
112
993
1.14
0.63
1.2
1.1
titre
47.0
95.6
—
5
32
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
93
814
1.15
0.63
2.0
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
63
1.59
0.61
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
182
1.32
0.61
2.5
2.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
50
1.60
0.61
1.0
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
136
1224
1.12
0.61
2.1
1.9
u/l
3915.9
2799.8
0.20
46
408
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
435
1.20
0.60
5.6
9.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
180
1647
1.10
0.60
1.6
1.6
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.1
—
0
10
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
746
0.85
0.59
1.5
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
61
519
1.18
0.59
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
61
519
1.18
0.59
1.4
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
10
151
0.66
0.59
1.1
1.3
umol/l
4.3
5.0
—
10
141
(3002032) Base excess in Venous blood by calculation
83
725
1.15
0.59
2.1
3.5
mmol/l
2.1
1.8
0.34
58
583
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
81
1.48
0.57
1.8
1.7
u/field
3.9
2.8
—
7
45
(40768797) Stomach Pathology biopsy report
207
1913
1.09
0.57
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
290
2719
1.08
0.56
1.4
1.4
titre
588.8
540.0
0.13
50
559
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
98
1.43
0.56
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
124
1.37
0.55
1.2
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
61
523
1.17
0.55
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
61
523
1.17
0.55
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
53
450
1.18
0.54
1.0
1.1
u/ml
1.4
0.8
0.50
18
174
(3036071) Salmonella sp Ab [Titer] in Serum
9
60
1.50
0.54
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
328
0.79
0.54
1.4
1.2
u/ml
188.5
271.9
1.46
17
222
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
87
982
0.88
0.54
3.7
3.6
ug/l
2.7
44.7
0.58
65
688
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
158
0.69
0.52
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
221
2371
0.92
0.52
1.6
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
304
0.79
0.52
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
83
1.45
0.51
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(4211845)
9
65
1.39
0.50
1.4
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
179
0.72
0.50
1.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
41
487
0.84
0.50
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
140
1280
1.10
0.50
2.3
2.2
au/ml
35.5
29.4
—
10
113
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
155
0.71
0.48
1.3
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
110
0.63
0.48
2.0
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
161
1485
1.09
0.48
1.5
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
74
836
0.88
0.48
1.2
1.3
u/ml
0.4
1.6
1.34
13
76
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
138
1264
1.10
0.48
4.3
4.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
166
0.72
0.48
2.9
4.1
u/ml
22.5
28.2
0.19
12
166
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
122
1337
0.91
0.47
3.6
3.2
%
31.6
32.2
0.22
99
1037
(3052851) Hemolysis interference index of Serum or Plasma
43
364
1.19
0.47
3.5
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
343
0.81
0.47
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
154
0.71
0.47
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
154
0.71
0.47
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
154
0.71
0.47
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
154
0.71
0.47
1.3
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
730
7513
0.95
0.46
5.0
6.0
%
29.6
29.8
0.34
669
7111
(44790048)
17
129
1.32
0.45
1.2
1.4
—
—
—
0
0
(44790047)
17
129
1.32
0.45
1.2
1.4
—
—
—
0
0
(3013512) EKG study
270
2856
0.94
0.45
2.1
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
186
0.75
0.44
1.0
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
175
1628
1.08
0.44
1.3
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
51
1.37
0.44
1.0
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
51
1.37
0.44
1.0
1.1
—
68.1
—
0
8
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
128
0.70
0.43
1.6
1.3
umol/l
7.9
9.6
—
9
119
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
227
2409
0.93
0.42
2.4
2.4
ug/g
102.3
100.0
0.03
189
1893
(3029075) Extractable nuclear Ab panel - Serum
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
60
528
1.14
0.42
1.1
1.1
u/ml
1.0
0.9
0.05
21
173
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
66
743
0.88
0.42
1.6
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
276
1.20
0.42
1.4
2.1
g/l
7.1
7.2
0.13
28
220
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
276
1.20
0.42
1.4
2.1
g/l
3.8
3.7
0.21
28
203
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
276
1.20
0.42
1.4
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
93
0.64
0.42
2.8
3.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
94
0.64
0.42
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
6
95
0.63
0.42
5.2
7.6
mg/l
14.3
11.1
—
6
90
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.9
—
23.8
—
0
15
(3048879) Bone marrow aspiration report
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
3.8
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
8.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
53
603
0.88
0.40
1.7
2.7
e9/l
76.0
73.0
0.19
39
455
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
295
2809
1.06
0.39
1.8
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
64
569
1.13
0.39
1.5
1.3
—
—
—
0
0
(3020891) Body temperature
35
297
1.18
0.39
2.7
4.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
357
3419
1.05
0.39
3.4
3.7
ph
7.4
7.4
0.03
42
652
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
104
0.67
0.39
1.1
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
15
193
0.78
0.39
1.0
1.1
%
104.0
95.8
0.52
15
183
(3006504) Eosinophils/100 leukocytes in Blood
701
7196
0.96
0.39
5.1
6.0
%
2.7
2.8
0.08
641
6776
(4281824)
18
226
0.79
0.39
1.3
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
52
590
0.88
0.38
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
124
1.29
0.38
1.4
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
158
1475
1.08
0.38
2.6
2.4
u/ml
27.2
34.2
0.87
152
1429
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
64
571
1.13
0.38
2.4
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
350
3354
1.05
0.38
3.7
3.3
%
100.0
100.1
0.02
341
3252
(3018010) Neutrophils/100 leukocytes in Blood
724
7422
0.96
0.37
5.0
5.8
%
56.7
56.4
0.30
666
7039
(3020874) Milk IgE Ab [Units/volume] in Serum
23
188
1.23
0.37
1.0
1.1
u/ml
0.3
0.4
—
9
56
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
113
0.71
0.37
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
113
0.71
0.37
1.5
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
211
2230
0.94
0.36
1.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
278
0.83
0.36
1.1
1.2
u/ml
7.6
2.9
0.60
11
105
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
187
1761
1.07
0.36
1.9
2.5
ng/l
623.0
385.1
0.32
148
1427
(3032773) Endomysium IgG Ab [Titer] in Serum
23
189
1.22
0.36
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
77
0.65
0.35
3.4
2.6
—
—
—
0
0
(4133840)
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
209
1978
1.06
0.35
1.9
2.3
umol/l
13.9
14.5
0.62
199
1867
(3021879) Hepatitis B virus core Ab [Presence] in Serum
135
1447
0.93
0.35
1.4
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
706
7231
0.96
0.35
5.2
6.2
%
7.7
7.9
0.86
651
6866
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
44
1.36
0.34
1.3
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
751
7680
0.96
0.34
5.1
6.0
e9/l
0.0
0.0
0.59
649
6865
(3000492) Spirometry study
179
1689
1.07
0.33
1.3
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
82
896
0.91
0.33
1.5
1.9
g/l
1.4
1.3
0.08
77
839
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
133
0.75
0.33
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
133
0.75
0.33
1.3
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
133
0.75
0.33
1.4
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
22
264
0.83
0.33
2.5
3.9
mmol/l
1.3
1.3
0.06
22
258
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
256
1.17
0.33
1.2
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
749
7655
0.96
0.33
5.1
6.0
e9/l
0.5
0.5
0.89
652
6865
(3022096) Basophils/100 leukocytes in Blood
680
6962
0.96
0.33
5.1
6.0
%
0.7
0.7
1.25
621
6547
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
220
0.82
0.32
1.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
372
3588
1.05
0.32
1.3
1.4
g/l
2.1
2.1
0.11
241
2413
(3051651) Icteric interference index of Serum or Plasma
10
74
1.35
0.32
5.9
2.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
539
0.89
0.32
1.5
1.6
iu/ml
0.0
34.3
0.50
15
97
(4027681)
18
146
1.24
0.32
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
132
0.76
0.32
1.2
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
11
143
0.77
0.32
13.8
12.8
mmol/l
0.6
0.6
0.79
11
129
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
170
1799
0.94
0.32
1.2
1.2
iu/ml
134.1
154.2
0.38
75
764
(40768441) Liver Pathology biopsy report
15
119
1.26
0.31
2.6
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
230
0.82
0.31
2.0
1.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
52
1.35
0.31
1.0
1.1
—
83.6
—
0
9
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
326
0.86
0.31
1.7
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1547
15353
1.05
0.31
10.5
10.7
%
39.7
39.9
0.35
1327
13212
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
158
1674
0.94
0.31
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
106
986
1.08
0.30
3.6
3.4
—
—
—
0
0
(44790049)
16
129
1.24
0.30
1.2
1.4
—
—
—
0
0
(44806118)
16
129
1.24
0.30
1.2
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
55
1.27
0.30
4.0
5.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
102
1.28
0.30
1.5
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
12
93
1.29
0.30
1.0
1.1
—
7.2
—
0
19
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
103
958
1.08
0.29
1.4
1.4
miu/ml
202.6
224.3
0.26
46
498
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
278
1.15
0.29
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
49
439
1.12
0.29
1.2
1.3
titre
108.0
93.3
—
5
46
(3006462) Nitrate [Presence] in Urine
7
56
1.25
0.29
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
37
419
0.88
0.29
1.1
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
783
7980
0.97
0.29
5.2
6.3
e9/l
0.2
0.2
0.23
717
7251
(3001019) Free T4 and TSH panel - Serum or Plasma
200
1906
1.06
0.28
1.6
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
173
0.81
0.28
1.2
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
167
1.20
0.28
1.2
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
11
140
0.78
0.28
1.0
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
12
94
1.28
0.28
1.7
1.7
%
52.2
37.4
0.90
12
52
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
62
1.29
0.28
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
697
7113
0.97
0.28
2.1
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
149
1.21
0.27
1.3
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
183
0.82
0.27
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
140
1.22
0.27
1.3
1.3
—
—
—
0
0
(44813793)
17
140
1.22
0.27
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
119
0.76
0.27
1.1
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
14
113
1.24
0.26
1.2
1.6
mmol/l
53.4
68.3
—
7
91
(4268621)
16
193
0.83
0.26
1.9
2.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
73
1.23
0.25
1.0
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
73
1.23
0.25
1.1
1.2
u/l
167.9
254.8
—
9
63
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
123
1.22
0.25
1.1
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
456
4678
0.97
0.25
5.2
6.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
61
663
0.92
0.24
4.0
8.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
137
0.80
0.24
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
66
610
1.09
0.24
1.5
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
168
0.83
0.22
1.4
3.2
—
1.2
—
0
22
(1001926) Buprenorphine [Presence] in Urine by Screen method
63
680
0.92
0.22
1.7
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
65
700
0.93
0.22
1.7
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
135
0.81
0.22
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
101
1069
0.94
0.21
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
124
0.81
0.21
1.3
1.1
u/l
0.9
1.1
—
5
55
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
2.7
—
0
11
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(4094501)
31
277
1.12
0.21
1.1
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
39.4
—
0
12
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
12
0.00
0.21
0.0
7.3
—
5.9
—
0
12
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4010399)
92
867
1.06
0.21
1.4
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
251
0.87
0.21
4.0
4.7
u/ml
32.9
113.4
—
9
74
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
260.0
—
0
13
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
1.7
—
0
13
(3003577) Lead [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3007700) Barley IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3032080) INR in Blood by Coagulation assay
383
3736
1.03
0.20
4.0
4.9
inr
1.1
1.1
0.17
91
1273
(3022313) Gas panel - Capillary blood
31
345
0.90
0.20
2.5
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
124
1301
0.95
0.20
2.2
2.3
u/l
28.2
39.1
3.03
107
1112
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
123
0.81
0.20
1.1
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
50
541
0.92
0.19
1.4
1.9
ug/l
3.6
5.5
0.82
38
472
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
50
1.20
0.19
1.3
3.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
197
0.86
0.19
1.8
2.8
—
915.3
—
0
12
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
52
1.15
0.19
1.7
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
38
347
1.10
0.18
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
175
1.14
0.18
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
164
0.85
0.18
1.4
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
58
541
1.07
0.18
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
59
1.19
0.18
1.7
2.2
%
13.6
11.3
—
7
59
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
224
2309
0.97
0.17
1.6
1.7
%
1.3
1.3
0.38
213
2097
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
61
1.15
0.17
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
88
927
0.95
0.17
1.5
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
165
1591
1.04
0.17
1.6
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
784
7939
0.98
0.17
5.0
5.9
e9/l
1.9
2.0
0.67
711
7214
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
129
1.16
0.17
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
120
0.83
0.16
3.9
3.3
u/ml
484.7
700.5
—
10
120
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
92
1.20
0.16
1.2
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
126
1211
1.04
0.16
2.6
2.4
e9/l
3.8
4.0
0.68
106
1029
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
72
1.11
0.16
1.1
2.3
umol/l
30.4
28.7
—
8
67
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
214
0.89
0.15
2.0
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
214
0.89
0.15
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
168
1.13
0.15
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
302
2952
1.03
0.15
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
197
1.12
0.15
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
197
1.12
0.15
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
214
2081
1.03
0.15
1.9
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
140
0.86
0.15
1.6
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
255
0.90
0.15
1.2
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
121
1.16
0.15
1.4
2.2
%
53.5
65.6
1.08
14
121
(3027008) Opiates [Presence] in Urine
88
921
0.95
0.14
1.5
1.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
87
0.80
0.14
1.0
1.1
%
116.7
109.5
—
7
75
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
87
0.80
0.14
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
90
0.78
0.14
3.0
2.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
90
0.78
0.14
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
116
1204
0.96
0.14
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
88
919
0.96
0.14
1.5
1.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
25
274
0.91
0.13
1.1
1.4
—
43.3
—
0
23
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
170
1.12
0.13
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
57
602
0.95
0.13
1.2
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
109
0.82
0.13
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
20
221
0.90
0.12
1.1
1.8
—
39.8
—
0
13
(3000764) Benzodiazepines [Presence] in Urine
88
916
0.96
0.12
1.5
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
85
816
1.04
0.12
2.8
3.5
ng/l
75.6
75.5
0.00
79
740
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
48
507
0.95
0.11
1.4
1.3
u/ml
2.6
10.2
—
7
92
(3004789) Transferrin [Mass/volume] in Serum or Plasma
180
1756
1.03
0.11
1.8
2.3
g/l
2.5
2.5
0.01
169
1652
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
38
404
0.94
0.11
1.4
1.3
mg/l
565.3
442.3
0.39
38
387
(3023183) Ammonium ion [Moles/volume] in Plasma
20
182
1.10
0.11
7.0
2.6
umol/l
40.4
31.8
0.77
20
163
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
188
0.90
0.11
1.3
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
49
465
1.06
0.11
1.1
1.1
u/ml
3.4
1.3
0.54
13
99
(3004588) Protein electrophoresis panel - Serum or Plasma
45
475
0.95
0.11
1.4
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
96
1.15
0.10
1.2
1.9
mmol/l
4.0
3.9
1.51
11
96
(3035285) Chloride [Moles/volume] in Venous blood
11
96
1.15
0.10
1.2
1.9
mmol/l
107.2
105.5
0.65
11
96
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
339
1.06
0.10
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
1573
1.03
0.10
1.9
2.4
%
23.5
23.7
0.09
143
1382
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
114
0.88
0.09
2.4
1.4
promille
1.1
1.0
—
10
87
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
184
1.09
0.09
1.7
3.4
u/ml
0.3
0.3
0.24
12
99
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1417
14218
0.98
0.09
7.2
8.1
ml/min/173m2
93.4
91.9
3.15
1189
11835
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
196
0.92
0.09
1.1
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
54
1.11
0.09
1.7
1.2
pmol/l
9.0
14.9
—
6
46
(3023430) Cat dander IgE Ab [Units/volume] in Serum
40
380
1.05
0.09
1.1
1.1
u/ml
5.3
3.1
0.44
15
137
(3005719) IgG [Mass/volume] in Serum or Plasma
112
1150
0.97
0.09
2.2
2.6
g/l
10.1
10.7
1.23
106
1067
(46235355) HIV 1 and 2 tests - Meaningful Use set
391
3866
1.01
0.08
1.8
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
64
1.09
0.08
1.0
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
10
88
1.14
0.08
2.4
3.0
mg/l
9.2
115.5
—
5
57
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
86
885
0.97
0.08
1.7
1.8
mg/l
2.3
3.5
2.42
66
625
(3005033) Fetal Nuchal fold Thickness US
50
480
1.04
0.08
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
166
1.09
0.07
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
166
1.09
0.07
1.1
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
90
925
0.97
0.07
1.9
2.5
%
1.7
1.7
0.05
77
818
(4024509)
6
71
0.84
0.07
1.5
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
72
0.83
0.07
1.2
3.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
225
0.93
0.07
2.6
4.0
mmol/l
3.8
3.7
0.74
21
207
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
75
1.07
0.07
1.0
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
76
1.05
0.07
1.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
184
0.92
0.07
1.4
1.6
—
—
—
0
0
(4306422)
30
284
1.06
0.07
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
82
0.85
0.07
1.1
1.1
miu/ml
1850.0
1511.2
—
7
82
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
57
551
1.04
0.07
2.0
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
122
1196
1.02
0.06
1.3
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
152
0.92
0.06
1.1
1.2
u/ml
0.0
1.6
—
7
60
(3047352) Trisomy 18 risk [Likelihood] in Fetus
50
483
1.04
0.06
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
345
0.96
0.06
1.5
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
355
0.96
0.06
1.4
1.4
e6/l
27.9
20.6
0.15
28
275
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
30
286
1.05
0.06
1.8
1.8
g/l
1.2
1.4
0.57
25
243
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
182
0.93
0.05
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
126
1238
1.02
0.05
1.5
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
58
597
0.97
0.05
2.0
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
188
1.06
0.05
2.2
2.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
90
1.11
0.05
1.1
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
354
0.96
0.05
1.5
1.4
e6/l
18071.2
690.6
0.46
28
288
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
43
445
0.97
0.05
1.7
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
81
828
0.98
0.05
1.5
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
325
3222
1.01
0.05
1.9
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
52
507
1.03
0.04
2.3
2.2
iu/l
3.3
4.0
0.47
21
244
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
119
0.92
0.04
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
210
0.95
0.03
2.1
3.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
300
0.97
0.03
2.3
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
33
320
1.03
0.03
3.4
3.4
g/l
0.2
0.3
0.42
13
130
(40768804) Tissue Pathology biopsy report
710
7078
1.01
0.03
2.0
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
145
1436
1.01
0.03
3.5
3.4
pmol/l
4.5
4.5
0.08
130
1286
(3000475) Leukocytes [#/volume] in Synovial fluid
24
231
1.04
0.02
1.6
1.7
e6/l
5574.6
6277.4
0.14
19
171
(3038177) Helicobacter pylori Ab [Presence] in Serum
39
400
0.97
0.02
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
35
341
1.03
0.02
1.1
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
41
419
0.98
0.02
1.0
1.1
u/ml
9.9
2.7
0.48
13
134
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
288
0.97
0.02
1.7
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
869
8676
1.00
0.01
7.5
9.4
e9/l
4.1
4.0
0.91
769
7743
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
153
1.05
0.01
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
153
1.05
0.01
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
153
1.05
0.01
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
157
0.96
0.01
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
157
0.96
0.01
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
157
0.96
0.01
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
160
1590
1.01
0.01
1.9
2.1
nmol/l
376.0
364.5
0.41
150
1468
(3002256) Pathology report gross observation
206
2070
0.99
0.01
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
263
1.03
0.01
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
180
1791
1.01
0.01
2.7
3.4
mmol/l
0.8
0.8
0.00
171
1703
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
124
1.05
0.00
1.1
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
136
0.96
0.00
5.8
7.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
137
1363
1.01
0.00
1.3
1.3
u/ml
110.7
232.2
0.94
132
1259
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
135
1.04
0.00
1.1
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
245
0.98
0.00
1.3
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
26
255
1.02
0.00
1.2
3.6
nmol/l
0.9
0.8
0.12
20
227
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
255
1.02
0.00
4.9
6.4
iu/ml
503.2
452.3
—
6
29
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
159
1.01
0.00
2.0
1.4
g/l
0.9
1.0
0.62
16
159
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
471
1.00
0.00
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
114
0.96
0.00
1.4
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
116
1.03
0.00
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
134
0.97
0.00
1.3
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
38
376
1.01
0.00
1.9
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
414
0.99
0.00
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
47
474
0.99
0.00
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
53
534
0.99
0.00
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
68
684
0.99
0.00
2.7
2.2
u/l
36.7
40.5
1.02
63
644
(3003396) Base excess in Arterial blood by calculation
91
914
1.00
0.00
4.4
6.8
mmol/l
0.6
1.0
0.41
66
681
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1187
11875
1.00
0.00
2.8
2.8
u/l
32.5
34.2
0.50
1157
11508
(3003740) Influenza virus B Ag [Presence] in Specimen
43
428
1.00
0.00
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
118
1.02
0.00
1.2
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
148
1.01
0.00
1.1
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
248
1.01
0.00
1.2
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
118
1.02
0.00
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
13
127
1.02
0.00
1.1
1.0
mg/l
280.7
309.9
0.61
13
113
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
197
1.02
0.00
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
27
273
0.99
0.00
1.8
1.3
u/ml
112.3
114.3
—
10
63
(3002523) Influenza virus A Ag [Presence] in Specimen
43
427
1.01
0.00
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
51
507
1.01
0.00
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
47
473
0.99
0.00
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
54
543
0.99
0.00
1.5
2.0
s
21.6
20.5
0.57
42
449
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
274
2745
1.00
0.00
1.4
1.4
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
49
1.02
0.00
1.4
2.0
ug/l
8.4
7.7
—
5
49
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
53
0.94
0.00
1.4
2.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
51
0.98
0.00
1.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
88
0.91
0.00
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.3
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.6
—
40.3
—
0
9
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.2
—
35.7
—
0
6
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.4
2.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
2.9
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
390
1.00
0.00
1.1
1.1
u/ml
1.4
2.6
1.44
22
235
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
4.6
—
490.2
—
0
5
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
65
0.92
0.00
1.3
2.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
57
0.88
0.00
1.0
1.8
umol/l
18.2
17.7
—
5
50
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
88
0.91
0.00
1.1
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.3
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
82
0.98
0.00
1.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.4
2.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
40.4
—
0
7
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
230.8
—
0
6
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.3
2.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
80
1.00
0.00
2.3
1.7
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
61
0.98
0.00
28.8
32.6
ug/l
8.3
7.1
—
6
56
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
120.0
—
0
9
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
236.8
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint O15_MATERN_CARE_DISPROP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_MATERN_CARE_DISPROP | 0.535 [0.43, 0.67] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.104 |
During the follow-up period (1.1.1998 — 31.12.2019), 89 out of 11794 females with O15_MATERN_CARE_DISPROP died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_MATERN_CARE_DISPROP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.059% | No data |
| 5 | 0.321% | No data |
| 10 | 0.697% | No data |
| 15 | 1.412% | No data |
| 20 | 2.428% | No data |
Relationships between endpoints
↥Index endpoint: O15_MATERN_CARE_DISPROP – Maternal care for known or suspected disproportion
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data